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Summary
Objective:  To  assess  the  agreement  between  the  tuberculin  skin  test  (TST)  and  the
QuantiFERON-TB  Gold  test  (QFT-G)  as  pre-employment  screening  tests  for  latentHealthcare  workers;
Tuberculin  skin  test;
QuantiFERON-TB  Gold
test
tuberculosis  infection  (LTBI)  among  healthcare  workers.
Methods:  A  retrospective  cross-sectional  study  was  conducted  among  1412  health-
care  workers  who  were  screened  for  LTBI  during  the  period  from  August  2009  to
May  2011  at  a  tertiary-care  hospital  in  the  Kingdom  of  Saudi  Arabia  (KSA).  The  stud-
ied  population  was  screened  for  LTBI  using  both  TST  and  QFT-G  simultaneously.  The
agreement  between  both  tests  was  quantiﬁed  using  the  Kappa  coefﬁcient  ().
∗ Corresponding author at: Environmental Health and Occupational Health and Safety, Infection Prevention and Control Department,
AMC, P.O. Box 22490, Riyadh 2134, Kingdom of Saudi Arabia. Tel.: +966 550340192.
E-mail addresses: mhelaly72@gmail.com, mhelaly72@yahoo.com (M. El-Helaly).
ttp://dx.doi.org/10.1016/j.jiph.2014.07.012
876-0341/© 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.
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Results:  Comparing  the  results  of  QFT-G  with  TST,  the  tests  had  a  signiﬁcant  overall
agreement  of  73.7%  (1040/1412;    =  0.33;  p  <  0.01).  Negative  concordance  comprised
60.1%  of  the  results,  and  positive  concordance  comprised  13.5%.  However,  positive
TST  but  negative  QFT  comprised  16.3%  of  the  results,  and  negative  TST  but  positive
QFT-G  comprised  10.1%.  Concordance  was  signiﬁcantly  associated  with  young  age,
female  gender,  Saudi-born  nationals,  and  early  career  but  not  job  type  (clinical  versus
non-clinical)  nor  status  of  Bacillus  Calmette—Guerin  (BCG)  vaccination.
Conclusions:  This  study  demonstrated  73.7%  overall  agreement  between  TST  and  QFT-
G  results  among  healthcare  workers  during  pre-employment  screening  for  LTBI.  The
results  need  to  be  conﬁrmed  in  future  studies  before  recommending  QFT-G  as  a  pre-
employment  screening  test  for  LTBI.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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Saudi Arabian  National  Guard  (SANG)  employees
and their  families.  According  to  2010  hospital  statis-
tics, healthcare  services  were  provided  by  11,461
healthcare  workers  including  1144  physicians,Ltd.  All  rights  reserved.
Introduction
Tuberculosis  (TB)  infection  represents  a global
health problem  and  a  great  risk  to  healthcare  work-
ers (HCWs)  [1].  Identifying  individuals,  particularly
HCWs,  with  latent  tuberculosis  infection  (LTBI)
supports  TB  control  programs.  Together  with  appro-
priate chemoprophylaxis,  it  can  prevent  infected
individuals from  developing  active  TB  [1].  Because
TB-infected  patients  eventually  present  themselves
to healthcare  providers  [2—4], HCWs  are  especially
vulnerable to  TB  exposure  and  infection  [5]. All
HCWs who  have  duties  that  involve  face-to-face
contact with  patients  with  suspected  or  conﬁrmed
TB (including  transport  staff)  should  be  included  in
a TB  screening  program  [6].
Despite the  conﬁrmed  limitations,  TB  screening
in HCWs  has  been  traditionally  conducted  using
the tuberculin  skin  test  (TST).  Yet,  TST  is  the  only
test for  which  the  risk  of  developing  active  TB
in persons  with  a  positive  result  has  been  well
deﬁned [7—9]. Recently,  interferon  gamma  release
assays  (IGRAs)  have  been  increasingly  used  for  LTBI
screening.  In  2001,  the  QuantiFERON-TB  test  (QFT)
became  the  ﬁrst  IGRA  approved  by  the  Food  and
Drug Administration,  followed  by  the  QuantiFERON-
TB Gold  test  (QFT-G),  the  QuantiFERON-TB  Gold
In-Tube  test  (QFT-GIT)  and  the  T-SPOT.TB  test  (T
Spot) [10].
Several systematic  reviews  have  suggested  that
IGRAs are  sensitive  and  more  speciﬁc  than  TST  in
identifying  LTBI,  particularly  in  low  TB-incidence
settings [11—14]. However,  the  use  of  IGRAs  for
routine screening  of  HCWs  remains  an  area  of
controversy.  For  example,  the  Canadian  guide-
lines among  others  have  not  endorsed  IGRAs  for
2
a
oerial  testing  in  a  healthcare  setting  [15,16].  Addi-
ionally, several  studies  have  reported  high  rates
f within-subject  variability,  high  rates  of  dis-
ordant  test  results  and  high  rates  of  conversions
nd reversions  among  HCWs  screened  with  these
ovel  assays  [2,15,17]. Nevertheless,  the  use  of
GRAs in  routine  screening  of  HCWs  has  been
ncreasing [17]. More  research  on  the  agreement
etween TST  and  IGRAs  is  required,  especially
mong healthcare  workers  [17]  particularly  in  low-
nd middle-income  countries,  which  traditionally
ave a high  TB  burden.  Although  the  Kingdom  of
audi Arabia  (KSA)  is  considered  a  high-income
ountry, it  hosts  a very  huge  labor  force  from
igh TB-endemic  countries  [18]  including  South-
ast Asian,  African  and  Middle  Eastern  countries
18,19].  The  objective  of  the  current  study  was
o assess  the  agreement  between  TST  and  QFT-G
mong  HCWs  at  a  tertiary-care  hospital  in  Riyadh,
SA.
ethods
opulation
his  study  was  carried  out  at King  Abdulaziz  Medical
ity (KAMC)  hospital  in  Riyadh,  KSA,  which  is  a  900-
ed tertiary-care  hospital  that  provides  primary,
econdary and  tertiary  healthcare  services  for  the812 nurses,  126  dentists,  197  pharmacists,  2095
llied health  personnel,  5087  administrators  and
thers.
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are-employment  screening  of  latent  tuberculosis  in
tudy design
e  identiﬁed  and  reviewed  all  the  pre-employment
xamination  health  records  for  HCWs  (N  =  3156)
ho were  screened  for  LTBI  at  KAMC  during  the
eriod from  August  2009  to  May  2011.  Among  the
156 HCWs,  only  1440  were  screened  by  both  TST
nd QFT-G  (per  the  hospital  policy  at  the  time  of
heir examination),  and  they  comprised  the  studied
opulation.  We  excluded  HCWs  who  were  younger
han 18  years  old  or  had  a  personal  history  of
uberculosis, immune-compromised  disease,  previ-
us diagnosis  of  LTBI  or  pregnancy.  The  study  was
pproved  by  the  ethical  (Institutional  Review  Board
r Bioethics)  committee  of  the  King  Abdullah  Inter-
ational  Medical  City  Research  Center  (KAIMRC).
The studied  population  was  screened  for  LTBI
sing both  TST  and  QFT-G  simultaneously.  Prior
dministration  of  the  Bacillus  Calmette—Guerin
BCG) vaccination  was  assessed  by  the  presence
f scars.  TST  was  performed  by  trained  per-
onnel following  standard  procedures.  In  brief,
.1 mL  (2  TU)  of  puriﬁed  protein  derivative  (RT23;
tatens  Serum  Institute,  Copenhagen,  Denmark)
as injected  intradermally  on  the  volar  side  of  the
orearm,  and  the  transverse  diameter  of  the  indura-
ion was  read  48—72  h  later.  An  induration  of  10  mm
iameter or  more  was  considered  positive.  Only
ne-step  TST  results  are  reported  here  because  the
ajority of  the  employees  either  did  not  show  up
or the  second  appointment  for  TST  or  refused  to
o the  two-step  TST.
Before  TST  application,  a  blood  sample  for
he QFT-G  was  drawn.  The  QFT-G  Assay  (Cellestis
imited, Carnegie,  Australia)  was  administered  fol-
owing the  manufacturer’s  protocol  [20]. The  QFT-G
ssay was  considered  positive  or  negative  based  on
he IFN-  concentration  cutoff  value  of  0.35  IU/mL.
tatistical methods
oth  TST  and  QFT-G  status  were  recorded  as  posi-
ive or  negative.  Agreement  between  the  tests  was
uantiﬁed  using  the  Kappa  coefﬁcient.  Kappa  ()
alues below  0.40  were  considered  fair  correlation;
alues of  0.41—0.60  were  considered  good  agree-
ent and  values  above  0.60  were  considered  strong
greement.  The  linear  association  between  the  TST
nduration  diameter  and  QFT-G  positivity  was  eval-
ated using  the  Mantel—Haenszel  chi-square  test.
he risk  factors  for  a  positive  TST  or  QFT-G  test
ere evaluated  using  odds  ratios  (ORs).  A  logistic
egression model  was  used  to  adjust  for  exposure
ariables chosen  on  the  basis  of  biological  plausi-
ility  and  on  statistical  criteria  and  included  age,
ender,  place  of  birth,  job  title  and  duration  of  work
a
t
d
pion  483
n  healthcare  facilities.  The  association  between
he above  sociodemographic  characteristics  and
he agreement  status  of  both  tests  was  examined
sing a chi-square  test.  Differences  were  consid-
red signiﬁcant  when  the  p  value  was  less  than  0.05
nd highly  signiﬁcant  when  the  p  value  was  less
han 0.01.  All  analyses  were  performed  using  the
PSS statistical  software  for  Windows  (SPSS  version
6.0; SPSS  Inc.,  Chicago,  IL,  USA).
esults
f  the  1440  HCWs  studied,  28  were  excluded  from
he analysis,  including  5  pregnant  individuals  and  23
ndividuals younger  than  18  years.  The  ﬁnal  sample
as 1412  HCWs  with  a mean  age  of  30.25  ±  7.95  and
ho were  predominantly  female  (66.5%).  The  HCWs
xamined  were  nurses  (38.7%),  physicians  (14.0%),
ther clinical  staff  (23.4%)  and  non-clinical  staff
23.9%).  The  majority  of  the  HCWs  (92.6%)  received
he BCG  vaccination.  Approximately  half  (48.6%)  of
he HCWs  were  born  in  Asian  countries,  while  39.9%
ere born  in  Saudi  Arabia.  Approximately  one  third
f the  HCWs  (33.1%)  had  worked  in  healthcare  facil-
ties for  5—10  years,  and  close  to  30%  had  worked
n a  healthcare  environment  for  10—15  years.  Only
.2% of  the  HCWs  had  worked  in  a healthcare  set-
ing for  more  than  20  years,  and  10.5%  of  the  HCWs
ad just  started  working  in  a healthcare  setting
Table  1).
Among the  1412  HCWs,  the  TST  was  posi-
ive in  421  (29.8%),  and  the  QFT-G  was  positive
n 333  (23.6%).  The  TST  was  negative  in  991
70.2%), and  the  QFT  was  negative  in  1079  (76.4%)
Table  2).  Comparing  the  results  of the  QFT-G
ith those  of  the  TST,  both  tests  had  a signiﬁcant
verall agreement  of  73.7%  (1040/1412;    =  0.33;
 <  0.01).  Negative  concordance  comprised  60.1%
f the  results,  and  positive  concordance  com-
rised 13.5%.  However,  positive  TST  but  negative
FT comprised  16.3%  of  the  results,  and  nega-
ive TST  but  positive  QFT-G  comprised  only  10.1%
Table  2).  Moreover,  there  was  a signiﬁcant  posi-
ive association  between  increasing  TST  induration
iameter and  QFT-G  positivity  (Mantel—Haenszel
hi-square  =  179.7,  p  <  0.01;  data  not  shown).
For the  overall  study  population,  26.4%  of  the
esults were  discordant  for  the  TST  and  QFT-G  tests
Table  3).  This  proportion  was  signiﬁcantly  lower
mong  those  of  younger  age  (23.7%  among  those
ged 19—29  years  compared  with  31.0%  among
hose aged  40  years  or  over,  p  <  0.05),  female  gen-
er (22.2%  compared  with  28.4%  among  males,
 <  0.05),  those  born  in  Saudi  Arabia  (20.1%  versus
484  
Table  1  Characteristics  of  1412  HCWs  undergoing
pre-employment  screening  for  LTBI  in  KAMC-Riyadh,
2009—2011.
Characteristic  N  %
Age:  30.25  ±  7.95  (mean  ±  SD)
19—29  yrs  811  57.4
30—39  yrs  417  29.5
40—49  yrs 141  10.0
50—60  yrs 43  3.0
Gender
Female  939  66.5
Male  433  33.5
Place  of  birth
Saudi  Arabia  563  39.9
Europe  70  5.0
North  America  a  30  2.1
Africa  53  3.8
Australia  10  0.7
Asia  686  48.6
BCG  vaccination
No  104  7.4
Yes  1308  92.6
Job  title
Non-clinical  staff  338  23.9
Nursing  547  38.7
Physician 197  14.0
Other  clinical  staff 330  23.4
Work  duration  in  healthcare
Start  of  work  148  10.5
<5  yrs 103  7.3
5—<10  yrs 467  33.1
10—<15  yrs 407  28.8
15—<20  yrs 214  15.2
≥20  yrs 73  5.2
yrs, years.
Table  2  Comparison  of  QFT-G  and  TST  among  1412
HCWs  undergoing  pre-employment  screening  for  LTBI,
in  KAMC-Riyadh,  2009—2011.
QFT-G  TST
Negative  Positive  Total
Negative  849  230  1079
Positive  142  191  333
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Overall agreement of 73.7% (1040/1412;  = 0.33, p < 0.01).
30%  or  more  among  those  born  outside  Saudi  Ara-
bia, p  <  0.01),  and  those  who  had  just  started
working in  this  environment  (14.9%  compared  with
29.3% among  those  started  work  10  years  or  more,
p <  0.01).  However,  job  type  (clinical  versus  non-
clinical)  and  status  of  BCG  vaccination  were  not
associated  with  the  concordance  of  the  results  of
both tests  (p  >  0.05)  (Table  3).
Positive  TST  results  were  signiﬁcantly  associated
with older  age  with  an  OR  =  2.5  (95%  CI:  1.91—3.21)
T
o
p
TM.  El-Helaly  et  al.
or  age  group  30—39  years  and  OR  =  3.6  (95%  CI:
.45—5.15) for  age  group  40—49  years.  However,
ositive results  from  either  the  TST  or  the  QFT-G
ests were  not  signiﬁcantly  associated  with  gen-
er, place  of  birth,  job  title,  and  work  duration  in
ealthcare  facilities  (Table  4).
iscussion
hile  TST  has  been  successfully  used  in  TB
nfection-control  programs,  the  availability  and
rowing use  of  IGRAs  raised  the  issue  of  whether
GRAs could  replace  TST  for  the  screening  of  LTBI  in
CWs [17]. The  current  study  examined  the  agree-
ent  between  TST  and  QFT-G  as  pre-employment
creening tests  for  LTBI  among  healthcare  workers.
In the  current  study,  comparing  the  results  of
he QFT-G  and  TST  tests,  both  tests  had  a  sig-
iﬁcant overall  agreement  of  73.7%  with  a  Kappa
oefﬁcient  of  0.33,  which  can  be  considered  fair.
his agreement  was  supported  by  the  increasing
robability of  positive  QFT-G  among  HCWs  with
 larger  induration  diameter  of  the  TST,  which
as in  accordance  with  other  studies  [5,21—24].
hao et  al.  reported  an  overall  agreement  between
he QFT-G  and  TST  of  75%.  Other  studies  reported
air to  moderate  agreement  between  QFT-G  and
ST results  ( =  0.346  and    = 0.5)  [5,20]. However,
thers reported  poor  and  insigniﬁcant  agreement
 =  0.115)  [23,25]. The  current  ﬁndings  showed
hat negative  concordance  comprised  60.1%  of the
esults, and  positive  concordance  comprised  13.5%.
n Saudi  Arabia,  little  is  known  about  the  agreement
f TST  and  IGRAs  results  among  HCWs.  However,  a
ecent study  reported  75.5%  (  =  0.34)  agreement
etween TST  and  QFT-G  results  among  200  dialy-
is patients  with  a  positive  TST  rate  of  13%  and
ositive QFT-G  rate  of 32.5%  [26].  Another  study
eported  90.9%  ( =  0.46)  agreement  between  TST
nd T-SPOT  among  44  kidney  donors  and  60.15%
 =  0.07)  agreement  between  the  two  tests  among
33 hemodialysis  patients,  with  40%  of  them  having
iscordant  results  between  TST  and  T-SPOT  [27].
owever, the  sample  sizes  of  both  studies  were
mall, and  the  ﬁndings  cannot  be  safely  projected
o HCWs.
More  than  60%  of  the  discordant  results  in  the
urrent study  were  positive  TST  but  negative  QFT-
 results  (Table  2).  Similarly,  in  a recent  systematic
eview of  19  studies,  it  was  shown  that  positive
ST but  negative  IGRAs  was  the  predominant  type
f discordance  [17]. A  viable  explanation  for  this
attern of  discordance  in  HCWs  with  documented
ST is  false-positive  TST  results  [28],  which  is
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Table  3  Association  of  the  concordance  of  TST  and  QFT-G  results  with  demographic  and  occupational  character-
istics  of  1412  HCWs  undergoing  pre-employment  screening  for  LTBI,  KAMC-Riyadh,  2009—2011.
Concordant  results
(N  =  1040),  N  (%)
Discordant  results
(N  =  372),  N  (%)
p-Value
Age  <0.05
19—29  yrs  619  (76.3)  192  (23.7)
30—39  yrs  294  (70.5)  123  (29.5)
40+  yrs 127  (69.0) 57  (31.0)
Gender  <0.05
Female  368  (77.8) 105  (22.2)
Male  672  (71.6)  267  (28.4)
Place  of  birth  <0.01
Saudi  Arabia  450  (79.9)  113  (20.1)
Asia  478  (69.7)  208  (30.3)
Others  112  (68.7)  51  (31.3)
BCG  vaccination  >0.05
No  69  (66.3)  35  (33.7)
Yes  971  (74.2)  337  (25.8)
Job  title  >0.05
Non-clinical  staff  249  (73.7)  89  (26.3)
Clinical  791  (73.6)  283  (26.4)
Time  working  in  healthcare  <0.01
Start  of  work  126  (85.1)  22  (14.9)
<10  yrs  423  (74.2)  147  (25.8)
≥10yrs  491  (70.7)  203  (29.3)
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urther  supported  by  the  fact  that  most  of  our  study
opulation  (92.6%)  had  received  the  BCG  vaccine.
dditionally, the  ﬁndings  of  the  current  study  indi-
ated that  the  discordance  of  the  results  of  both
est varied  with  several  demographic  and  occupa-
ional  variables  (Table  3).  For  example,  young  Saudi
emales  who  had  just  started  their  work  in  this  set-
ing had  the  lowest  discordant  results,  which  may
ndicate that  they  would  be  good  candidates  for
FT-G tests  in  their  pre-employment  examination.
t has  been  shown  that  the  sensitivity  and  speci-
city of  IGRAs  in  identifying  LTBI  is  higher  than  that
f TST  among  those  in  a  low  TB-incidence  setting
11—14].
The current  ﬁndings  showed  that  the  prevalence
f LTBI  using  QFT-G  (23.6%)  is  signiﬁcantly  lower
han the  prevalence  of  LTBI  using  TST  (29.8%).  This
s in  agreement  with  several  studies  that  reported
 lower  prevalence  of  positive  QFT-G  than  positive
ST  results,  with  the  prevalence  of  positive  QFT-G
esults  ranging  from  1%  to  66.8%  [17,29].  The  ﬁnding
ay indicate  that  using  IGRAs  will  lead  to  fewer
CWs  requiring  preventive  therapy.
Some studies  reported  an  association  betweenST positivity  and  BCG  vaccination,  duration  of
ears working  in  healthcare  environment,  and  non-
ccupational  exposure  to  TB.  In  contrast,  QFT-G
ositivity  was  associated  with  having  worked  as
A
(
t
d HCW  but  not  with  BCG  vaccination  [5,15,30].
ur study  failed  to  show  a signiﬁcant  association
etween the  above  variables  and  positive  TST  and
FT-G results,  except  for  age,  which  increased  the
robability  of  a positive  TST  result.
Some studies  indicated  that  IGRAs  testing  includ-
ng QFT-G  is  better  than  TST  in  detecting  LTBI
25,28,29,31]. According  to  these  studies,  IGRA  is
ore speciﬁc  and  sensitive,  not  affected  by  BCG
accination,  needs  only  one  visit  to  the  test  unit,
nd avoids  the  variability  and  subjectivity  asso-
iated  with  the  application  and  reading  of  the
ST. However,  IGRA  is  more  expensive  than  TST
ecause it  requires  special  equipment  and  a skilled
aboratory  technician  and  is  subject  to  increased
ikelihood of  conversions  and  revisions  in  serial  test-
ng [4,5,24].
To  date,  there  is  no  consensus  to  replace  TST
ith IGRAs  for  LTBI  screening  among  HCWs.  How-
ver, some  countries,  such  as  the  USA,  have
ecommended the  use  of  IGRAs  for  HCW  screening
32], especially  for  BCG-vaccinated  HCWs  [29].  In
ontrast, other  guidelines  (e.g.,  Canada,  Australia,
K and  KSA)  [16,19,32,33]  have  been  cautious.
dditionally, in  2012,  the  World  Health  Organization
WHO) released  a  report  including  recommenda-
ions that  discourage  the  use  of  IGRAs  for  the
etection of  LTBI  in  HCWs  from  low-income  and
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Table  4  Frequency  and  adjusted  odds  ratios  (OR)  and  95%  conﬁdence  intervals  (CI)  for  covariates  associated  with
positive  results  on  the  TST  and  QFT-G  results  among  1412  HCWs  undergoing  pre-employment  screening  for  LTBI,  in
KAMC-Riyadh,  2009  —  2011.
TST  ≥  10  mm  QFT-positive
N  (%) OR  (95%  CI) N (%) OR  (95%  CI)
Age
19—29  yrs  172/811  (21.2)  1  134/811  (16.5)  1
30—39  yrs  167/417  (40.0)  2.5  (1.91—3.21)* 138/417  (33.1)  0.5  (0.26—1.02)
40—49  yrs  69/141(48.9)  3.6  (2.45—5.15)* 49/141(34.8)  1.3  (0.64—2.57)
50—60  yrs  13/43  (30.2)  1.6  (0.82—3.15)  12/43  (27.9)  1.4  (0.65—2.91)
Gender
Female  295/939  (31.4)  1  238/939  (25.3)  1
Male  126/433  (29.1)  1.3  (0.99—1.61)  95/433  (21.9)  0.7  (0.57—0.97)
Place  of  birth
Saudi  Arabia  96/563  (17.1)  1  63/563  (11.2)  1
Europe  22/70  (31.4)  0.3  (0.24—0.41)  9/70  (12.9)  0.2  (0.17—0.31)
North  America  3/30  (10.0)  0.7  (0.41—1.18)  3/30  (10.0)  0.3  (0.13—0.54)
Africa  26/53  (49.1)  0.2  (0.05—0.56)  12/53  (22.6)  0.2  (0.06—0.67)
Australia  3/10  (30.0)  1.5  (0.84—2.58)  1/10  (10.0)  0.5  (0.27—1.02)
Asia  271/686  (39.5)  0.7  (0.16—2.56)  245/686  (35.7)  0.2  (0.25—1.59)
Job  title
Non-clinical  staff  83/338  (24.6)  1  82/338  (24.3)  1
Nursing  staff  202/547  (36.9)  1.8  (1.33—2.43)  149/547  (27.2)  1.1  (0.77—1.59)
Physician  49/197  (24.9)  1.0  (0.66—1.53)  28/197  (14.2)  1.3  (0.94—1.78)
Other  clinical  staff  87/330  (26.4)  1.1  (0.78—1.56)  74/330  (22.4)  0.6  (0.36—0.92)
Time  working  in  healthcare
Start  of  work  13/148  (8.8)  1  11/148  (7.4)  1
<5  yrs  30/103  (29.1)  0.2  (0.07—0.32)  19/103  (18.4)  0.2  (0.09—0.44)
5—<10  yrs  110/467  (23.6)  0.7  (0.35—1.25)  98/467  (20.9)  0.6  (0.28—1.14)
10—<15  yrs 142/407  (34.9)  0.5  (0.29—0.83)  113/407  (27.8)  0.7  (0.38—1.14)
15—<20  yrs  98/214  (45.8)  0.9  (0.52—1.44)  71/214  (33.1)  0.9  (0.55—1.65)
≥20  yrs 28/73  (38.4)  1.4  (0.79—2.34)  21/73  (28.8)  1.2  (0.69—2.19)
t
o
d
a
C
T
T
e
r
b
s
Cyrs, years; CI, conﬁdence interval; OR, odds ratio.
* p < 0.05.
middle-income  countries  [19].  However,  Khoury
et al.  stated  that  the  need  for  a  strategy  with  low
false-positive  results  may  be  best  met  by  using  both
the TST  and  QFT-G,  which  would  enhance  the  speci-
ﬁcity of  detection.  This  may  further  represent  cost
savings by  decreasing  unnecessary  radiographs,
pharmacologic  treatment,  and  laboratory  surveil-
lance [28].
The current  study  bridges  the  local  knowledge
gab in  pre-employment  screening  for  LTBI.  Studying
a relatively  large  number  of  highly  diverse  HCWs
allowed us  to  examine  the  association  of  several
demographic and  occupational  characteristics  with
the concordance  of  the  TST/QFT-G  results.  Never-
theless,  we  acknowledge  some  limitations;  as  the
data are  from  a  single-center  retrospective  experi-
ence, the  ﬁndings  should  be  generalized  cautiously.
Because the  prevalence  of  BCG  vaccine  was  very
high (92.6%)  and  some  details  were  lacking  (such
as date  and  number  of  doses),  we  could  not  verify
the impact  of  the  BCG  on  the  concordance  of  both
Fests.  Due  to  the  study  design  and  the  availability
f the  data,  we  were  not  able  to  fully  examine  the
iscordant  pairs  or the  change  in  concordance,  if
ny, over  time.
onclusions
he  present  study  revealed  fair  agreement  between
ST  and  QFT-G  results  among  healthcare  work-
rs during  pre-employment  screening  for  LTBI.  The
esults need  to  be  conﬁrmed  in  future  studies
efore recommending  QFT-G  as  a pre-employment
creening test  for  LTBI.
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